Bellerophon Therapeutics, Inc. - stock earnings
BLPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.9 million USD | ? USD |
| 2023Q2 | -5.1 million USD | ? USD |
| 2023Q1 | 2.8 million USD | 5.6 million USD |
| 2022Q4 | -7.4 million USD | ? USD |
| 2022Q3 | -5.0 million USD | ? USD |
| 2022Q2 | -4.1 million USD | ? USD |
| 2022Q1 | -5.6 million USD | ? USD |
| 2021Q4 | -4.3 million USD | ? USD |
| 2021Q3 | -4.6 million USD | ? USD |
| 2021Q2 | -3.4 million USD | ? USD |
| 2021Q1 | -5.5 million USD | ? USD |
| 2020Q4 | -8.0 million USD | ? USD |
| 2020Q3 | -7.9 million USD | ? USD |
| 2020Q2 | -3.8 million USD | ? USD |
| 2020Q1 | -4.1 million USD | ? USD |
| 2019Q4 | -4.1 million USD | ? USD |
| 2019Q3 | -4.3 million USD | ? USD |
| 2019Q2 | -4.1 million USD | ? USD |
| 2019Q1 | -795000 USD | ? USD |
| 2018Q4 | -912000 USD | ? USD |
| 2018Q3 | 11.1 million USD | ? USD |
| 2018Q2 | -11.5 million USD | ? USD |
| 2018Q1 | 4.1 million USD | ? USD |
| 2017Q4 | -24.2 million USD | ? USD |
| 2017Q3 | -7.6 million USD | ? USD |
| 2017Q2 | -3.9 million USD | ? USD |
| 2017Q1 | -19.1 million USD | ? USD |
| 2016Q4 | -7.4 million USD | ? USD |
| 2016Q3 | -4.2 million USD | ? USD |
| 2016Q2 | -5.1 million USD | ? USD |
| 2016Q1 | -7.1 million USD | ? USD |
| 2015Q4 | -10.8 million USD | ? USD |
| 2015Q3 | -11.1 million USD | ? USD |
| 2015Q2 | -11.6 million USD | ? USD |
| 2015Q1 | -12.9 million USD | ? USD |
| 2014Q4 | -12.8 million USD | ? USD |
| 2014Q3 | -15.5 million USD | ? USD |
| 2014Q2 | -16.9 million USD | ? USD |
| 2014Q1 | -14.5 million USD | ? USD |
| 2013Q4 | -16.8 million USD | ? USD |
BLPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.3 million USD | 5.6 million USD |
| 2022 | -19.8 million USD | 5.6 million USD |
| 2021 | -17.8 million USD | ? USD |
| 2020 | -24.7 million USD | ? USD |
| 2019 | -13.3 million USD | ? USD |
| 2018 | 2.8 million USD | ? USD |
| 2017 | -54.8 million USD | ? USD |
| 2016 | -23.8 million USD | ? USD |
| 2015 | -46.5 million USD | ? USD |
| 2014 | -59.7 million USD | ? USD |
| 2013 | -62.0 million USD | ? USD |
| 2012 | -46.2 million USD | ? USD |
BLPH
Price: $0.06
52 week price:
Earnings Per Share: -0.89 USD
P/E Ratio: -0.07
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 18100
Ebitda: -6.1 millionMarket Capitalization: 733956